Ansell Ltd (ASX:ANN) is a global leader in safety solutions and an integrated manufacturer of personal protective equipment for healthcare and industrial workplaces. More than 10 million workers in over 100 countries use Ansell brands such as HyFlex, Ringers, MICROFLEX, TouchNTuff, GAMMEX, Kimtech, KleenGuard and AlphaTec. The company operates through Industrial and Healthcare segments and reports in US dollars. Nathalie Ahlström is Managing Director and CEO.

On 2 October 2026, Ansell shares were trading at $44.55, up 0.41%. The company's full-year results, released in August, reported sales and Earnings growth and an FY27 outlook.

Recent Developments

On 24 August 2026, Ansell announced its results for the year ended 30 June 2026. Figures are in US dollars. Key points include:

  • Sales increased 6.8% to $2,140.2 million, or 5.0% on an organic constant currency basis.
  • Adjusted EBIT rose 14.1% to $321.9 million, with the Margin up 90 basis points to 15.0%.
  • Adjusted NPAT increased 15.8% to $212.3 million, and statutory NPAT rose 105.3% to $208.6 million.
  • Adjusted EPS was US148.6 cents, up 17.8%, in the upper half of guidance.
  • Operating cash flow rose 156.3% to $270.1 million, with cash conversion of 113%.
  • The final unfranked dividend was US41.5 cents, bringing full-year DPS to US68.1 cents, up 35.7%.
  • Share Buybacks totalled $118.4 million, and Net Debt/Adjusted EBITDA fell to 1.3 times.

Industrial segment sales were $947.3 million, up 3.3% organically, with adjusted EBIT of $170.6 million. Healthcare segment sales were $1,192.9 million, up 6.4% organically, with adjusted EBIT of $170.7 million, supported by 10% growth in Cleanroom sales. Ansell said sourcing actions and price increases offset US Tariff effects and cost Inflation from the Middle East crisis, and it received about $12 million in tariff refunds in July.

Ms Ahlström said FY26 was a successful year and that her focus will be on accelerating profitable growth through commercial excellence, strategic markets and operational excellence. The Accelerated Productivity Investment Program achieved its $50 million recurring savings target. For FY27, Ansell expects adjusted EPS of US158 cents to US170 cents, with capex of $45 million to $55 million and one-off costs of about $15 million, mainly for ERP implementation. The company will continue its $200 million buyback program and hold its AGM on 9 November 2026.

Mechanical sales grew 6.5% on an adjusted basis, supported by new products such as HyFlex precision comfort cut protection styles, while Chemical sales increased 0.5%. Exam and Single Use sales grew 5.6% on an adjusted basis, and Surgical sales increased 6.4%, driven by Demand for synthetic products. Adjusted EPS included a net benefit of US3.3 cents from non-recurring items. Currency movements were favourable to sales by $46.6 million, but a net foreign exchange loss of $13.8 million on hedge contracts made currency unfavourable to EBIT by $4.3 million overall. Ansell had $752 million of cash and undrawn bank facilities at 30 June 2026. The dividend is sourced from Ansell's Conduit Foreign Income Account and will not attract Withholding tax for non-resident shareholders.

Sector Context

Personal protective equipment demand is driven by workplace safety regulations, healthcare activity and industrial production. After the pandemic, the sector went through a period of destocking and price normalisation, before demand stabilised. Specialised segments such as cleanroom products for pharmaceuticals and semiconductors have shown growth.

Manufacturers face input cost volatility, including raw materials and energy, and trade policies such as US tariffs. Supply chain resilience has become a priority, and companies with diversified Manufacturing may be better able to manage disruptions.

Cleanroom products are used in pharmaceutical, medical device and semiconductor manufacturing, where contamination control is critical. Growth in these industries has supported demand for specialised gloves and garments. Industrial safety products are linked to manufacturing and construction activity, including aerospace and defence.

Ansell reported increased KBU synergies as one of the contributors to adjusted EBIT growth in FY26. Integration of acquired businesses is a common feature of the PPE sector as manufacturers seek scale.

Risks and Uncertainties

Ansell's earnings are exposed to tariff changes and cost inflation, and the company noted that the timeline for recovering remaining tariff refunds is uncertain. Some FY26 sales benefited from temporary customer stocking ahead of price increases. Currency and hedge book movements affect results. The ERP implementation carries execution risk. The dividend is unfranked, and global economic conditions remain uncertain.

Competition from lower-cost glove manufacturers, particularly in single-use products, could pressure prices. Further cost inflation from geopolitical events may require additional price increases, which customers may resist.

Legal costs associated with a Shareholder class action were recorded as significant items, and further legal matters could add costs.

Catalysts Investors Can Watch

Investors may watch for progress against FY27 EPS guidance, Cleanroom and US sales growth, the ERP rollout in North America, buyback execution and any changes in tariff settings. The AGM on 9 November 2026 may provide a trading update.

The new CEO's strategic priorities, including commercial excellence, strategic markets and operational excellence, may shape future announcements. FY27 assumptions include a foreign exchange benefit of about $9 million and net interest costs of about $43 million.

The progress of the ERP system upgrades and the remaining recovery of US tariff refunds may also be followed.

Key Takeaways

Ansell's FY26 result showed sales and earnings growth, higher dividends and cash conversion of 113% despite tariffs and cost inflation. FY27 guidance points to further EPS growth, with execution on commercial and operational initiatives central.

Its AGM in November may provide further detail on trading.